NDTV Profit's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer NDTV Profit's subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Motilal Oswal Report
Motilal Oswal Financial Services remains positive on Laurus Labs Ltd. on the back of-
- its strengthening position in gaining CDMO contracts from global innovator pharma companies,
- addition of a growth lever in the generics space, and
- steady ARV business.
The brokerage expects 16% CAGR in earnings over FY26-28. Motilal Oswal values Laurus at 62 times 12-month forward earnings to arrive at a target price of Rs 1,280. The brokerage maintains 'Buy' ratings on the stock.
Click on the attachment to read the full report:
ALSO READ: Maruti Suzuki, TVS Motor, M&M Among Motilal Oswal's Top Auto Stocks — Check Target Prices
DISCLAIMER
This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
